Home › Funds › Millennium Management › ANTX
Millennium Management position in ANTX
AN2 THERAPEUTICS INC · Health Care
Latest position (Q2 2026)2.32M sh
Reported value held$11.22M
Portfolio Weight0.00%
First reportedQ1 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 74.24K | $1.12M | New |
| Q2 2023 | 24.24K | $206.06K | New |
| Q4 2023 | 39.67K | $812.92K | New |
| Q1 2024 | 96.91K | $314.97K | Add |
| Q2 2024 | 526.35K | $1.13M | Add |
| Q3 2024 | 397.93K | $425.78K | Reduce |
| Q4 2024 | 209.37K | $288.93K | Reduce |
| Q1 2025 | 50.04K | $68.05K | Reduce |
| Q4 2025 | 95.68K | $109.08K | New |
| Q1 2026 | 2.22M | $7.60M | Add |
| Q2 2026 | 2.32M | $11.22M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ANTX
- BlackRock Inc 1.67M sh · $8.06M · Q2 2026
- Citadel Advisors 952.00K sh · $4.61M · Q2 2026
- Geode Capital Management 697.81K sh · $3.38M · Q2 2026
- Balyasny Asset Management 556.03K sh · $2.69M · Q2 2026
- Vanguard Group 1.08M sh · $1.23M · Q4 2025
- Northern Trust Corp 214.92K sh · $1.04M · Q2 2026
- Bank of America Corp 145.80K sh · $705.69K · Q2 2026
- Renaissance Technologies 129.70K sh · $627.75K · Q2 2026
- Goldman Sachs Group 87.93K sh · $425.60K · Q2 2026
- UBS Group AG 74.09K sh · $358.58K · Q2 2026
- BNY Mellon 67.68K sh · $327.55K · Q2 2026